Literature DB >> 20864924

Detection of Neu1 sialidase activity in regulating Toll-like receptor activation.

Schammim R Amith1, Preethi Jayanth, Trisha Finlay, Susan Franchuk, Alanna Gilmour, Samar Abdulkhalek, Myron R Szewczuk.   

Abstract

Mammalian Toll-like receptors (TLRs) are a family of receptors that recognize pathogen-associated molecular patterns. Not only are TLRs crucial sensors of microbial (e.g., viruses, bacteria and parasite) infections, they also play an important role in the pathophysiology of infectious diseases, inflammatory diseases, and possibly in autoimmune diseases. Thus, the intensity and duration of TLR responses against infectious diseases must be tightly controlled. It follows that understanding the structural integrity of sensor receptors, their ligand interactions and signaling components is essential for subsequent immunological protection. It would also provide important opportunities for disease modification through sensor manipulation. Although the signaling pathways of TLR sensors are well characterized, the parameters controlling interactions between the sensors and their ligands still remain poorly defined. We have recently identified a novel mechanism of TLR activation by its natural ligand, which has not been previously observed. It suggests that ligand-induced TLR activation is tightly controlled by Neu1 sialidase activation. We have also reported that Neu1 tightly regulates neurotrophin receptors like TrkA and TrkB, which involve Neu1 and matrix metalloproteinase-9 (MMP-9) cross-talk in complex with the receptors. The sialidase assay has been initially use to find a novel ligand, thymoquinone, in the activation of Neu4 sialidase on the cell surface of macrophages, dendritic cells and fibroblast cells via GPCR Gαi proteins and MMP-9. For TLR receptors, our data indicate that Neu1 sialidase is already in complex with TLR-2, -3 and -4 receptors, and is induced upon ligand binding to either receptor. Activated Neu1 sialidase hydrolyzes sialyl α-2,3-linked β-galactosyl residues distant from ligand binding to remove steric hinderance to TLR-4 dimerization, MyD88/TLR4 complex recruitment, NFkB activation and pro-inflammatory cell responses. In a collaborative report, Neu1 sialidase has been shown to regulate phagocytosis in macrophage cells. Taken together, the sialidase assay has provided us with powerful insights to the molecular mechanisms of ligand-induced receptor activation. Although the precise relationship between Neu1 sialidase and the activation of TLR, Trk receptors has yet to be fully elucidated, it would represent a new or pioneering approach to cell regulation pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864924      PMCID: PMC3157878          DOI: 10.3791/2142

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  6 in total

1.  Dependence of neurotrophic factor activation of Trk tyrosine kinase receptors on cellular sialidase.

Authors:  Alicja Woronowicz; Schammim R Amith; Kristof De Vusser; Wouter Laroy; Roland Contreras; Sameh Basta; Myron R Szewczuk
Journal:  Glycobiology       Date:  2006-09-13       Impact factor: 4.313

2.  Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for neurotrophin activation of Trk receptors and cellular signaling.

Authors:  Preethi Jayanth; Schammim Ray Amith; Katrina Gee; Myron R Szewczuk
Journal:  Cell Signal       Date:  2010-03-25       Impact factor: 4.315

3.  Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.

Authors:  Trisha M Finlay; Preethi Jayanth; Schammim Ray Amith; Alanna Gilmour; Christina Guzzo; Katrina Gee; Rudi Beyaert; Myron R Szewczuk
Journal:  Glycoconj J       Date:  2010-03-06       Impact factor: 2.916

4.  Regulation of phagocytosis in macrophages by neuraminidase 1.

Authors:  Volkan Seyrantepe; Alexandre Iannello; Feng Liang; Evgeny Kanshin; Preethi Jayanth; Suzanne Samarani; Myron R Szewczuk; Ali Ahmad; Alexey V Pshezhetsky
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

5.  Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase.

Authors:  Schammim Ray Amith; Preethi Jayanth; Susan Franchuk; Sarah Siddiqui; Volkan Seyrantepe; Katrina Gee; Sameh Basta; Rudi Beyaert; Alexey V Pshezhetsky; Myron R Szewczuk
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

6.  Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling.

Authors:  Schammim Ray Amith; Preethi Jayanth; Susan Franchuk; Trisha Finlay; Volkan Seyrantepe; Rudi Beyaert; Alexey V Pshezhetsky; Myron R Szewczuk
Journal:  Cell Signal       Date:  2009-09-29       Impact factor: 4.315

  6 in total
  24 in total

1.  Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathway.

Authors:  Jing Yang; Xiang-ru Kuang; Ping-tian Lv; Xi-xin Yan
Journal:  Tumour Biol       Date:  2014-09-20

2.  Neuraminidase activity mediates IL-6 production by activated lupus-prone mesangial cells.

Authors:  Kamala Sundararaj; Jessalyn I Rodgers; Subathra Marimuthu; Leah J Siskind; Evelyn Bruner; Tamara K Nowling
Journal:  Am J Physiol Renal Physiol       Date:  2017-12-20

3.  The role of neuraminidase in TLR4-MAPK signalling and the release of cytokines by lupus serum-stimulated mesangial cells.

Authors:  Kamala Sundararaj; Jessalyn Rodgers; Peggi Angel; Bethany Wolf; Tamara K Nowling
Journal:  Immunology       Date:  2021-01-24       Impact factor: 7.397

Review 4.  Cell-surface receptors transactivation mediated by g protein-coupled receptors.

Authors:  Fabio Cattaneo; Germano Guerra; Melania Parisi; Marta De Marinis; Domenico Tafuri; Mariapia Cinelli; Rosario Ammendola
Journal:  Int J Mol Sci       Date:  2014-10-29       Impact factor: 5.923

5.  Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma.

Authors:  Fiona Haxho; Stephanie Allison; Farah Alghamdi; Lacey Brodhagen; Victoria El Kuta; Samar Abdulkhalek; Ronald J Neufeld; Myron R Szewczuk
Journal:  Breast Cancer (Dove Med Press)       Date:  2014-12-09

6.  Anti-influenza neuraminidase inhibitor oseltamivir phosphate induces canine mammary cancer cell aggressiveness.

Authors:  Joana T de Oliveira; Ana L Santos; Catarina Gomes; Rita Barros; Cláudia Ribeiro; Nuno Mendes; Augusto J de Matos; M Helena Vasconcelos; Maria José Oliveira; Celso A Reis; Fátima Gärtner
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells.

Authors:  Bessi Qorri; William Harless; Myron R Szewczuk
Journal:  Drug Des Devel Ther       Date:  2020-10-08       Impact factor: 4.162

8.  Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance.

Authors:  Leah K O'Shea; Samar Abdulkhalek; Stephanie Allison; Ronald J Neufeld; Myron R Szewczuk
Journal:  Onco Targets Ther       Date:  2014-01-16       Impact factor: 4.147

9.  Transcriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma.

Authors:  Samar Abdulkhalek; Olivia D Geen; Lacey Brodhagen; Fiona Haxho; Farah Alghamdi; Stephanie Allison; Duncan J Simmons; Leah K O'Shea; Ronald J Neufeld; Myron R Szewczuk
Journal:  Clin Transl Med       Date:  2014-09-23

Review 10.  The Elastin Receptor Complex: A Unique Matricellular Receptor with High Anti-tumoral Potential.

Authors:  Amandine Scandolera; Ludivine Odoul; Stéphanie Salesse; Alexandre Guillot; Sébastien Blaise; Charlotte Kawecki; Pascal Maurice; Hassan El Btaouri; Béatrice Romier-Crouzet; Laurent Martiny; Laurent Debelle; Laurent Duca
Journal:  Front Pharmacol       Date:  2016-03-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.